James Meyers

James Meyers

Director/Board Member chez ARBUTUS BIOPHARMA CORPORATION

Fortune : 33 232 $ au 31/03/2024

58 ans
Health Technology
Commercial Services
Consumer Services

Profil

James R.
Meyers
is currently the President & Chief Executive Officer at IntraBio, Inc. He is also an Independent Director at Sangamo Therapeutics, Inc., a Director at the Biotechnology Innovation Organization, an Independent Director at Arbutus Biopharma Corp., a Director at Pulmocide Ltd., an Independent Director at CytomX Therapeutics, Inc., and a Director at the California Biomedical Innovation Alliance.
Previously, he worked at Gilead Sciences, Inc. as the Executive VP-Worldwide Commercial Operations from 2016 to 2018.
Mr. Meyers completed his undergraduate degree at Boston College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/06/2023 49 600 ( 0,02% ) 33 232 $ 31/03/2024
19/03/2024 0 ( -.--% ) - $ 31/03/2024
24/05/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de James Meyers

SociétésPosteDébut
ARBUTUS BIOPHARMA CORPORATION Director/Board Member 23/10/2018
CYTOMX THERAPEUTICS, INC. Director/Board Member 20/12/2018
SANGAMO THERAPEUTICS, INC. Director/Board Member 22/11/2019
Director/Board Member -
Director/Board Member -
Chief Executive Officer 24/11/2020
Director/Board Member -
Tous les postes actifs de James Meyers

Anciens postes connus de James Meyers

SociétésPosteFin
GILEAD SCIENCES, INC. Corporate Officer/Principal 22/02/2018
Voir l'expérience en détail de James Meyers

Formation de James Meyers

Boston College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Meyers

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
GILEAD SCIENCES, INC.

Health Technology

SANGAMO THERAPEUTICS, INC.

Health Technology

ARBUTUS BIOPHARMA CORPORATION

Health Technology

CYTOMX THERAPEUTICS, INC.

Health Technology

Entreprise privées4

Commercial Services

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Meyers